90 related articles for article (PubMed ID: 34663329)
1. Upregulation of SNTB1 correlates with poor prognosis and promotes cell growth by negative regulating PKN2 in colorectal cancer.
Liu L; Chen Y; Lin X; Wu M; Li J; Xie Q; Sferra TJ; Han Y; Liu H; Cao L; Yao M; Peng J; Shen A
Cancer Cell Int; 2021 Oct; 21(1):547. PubMed ID: 34663329
[TBL] [Abstract][Full Text] [Related]
2. SNTB1 regulates colorectal cancer cell proliferation and metastasis through YAP1 and the WNT/β-catenin pathway.
Zhang H; Li Z; Jiang J; Lei Y; Xie J; Liu Y; Yi B
Cell Cycle; 2023 Sep; 22(17):1865-1883. PubMed ID: 37592763
[TBL] [Abstract][Full Text] [Related]
3. Musashi-2 Deficiency Triggers Colorectal Cancer Ferroptosis by Downregulating the MAPK Signaling Cascade to Inhibit HSPB1 Phosphorylation.
Meng X; Peng X; Ouyang W; Li H; Na R; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Zhuang G; Tang H; Peng Z
Biol Proced Online; 2023 Dec; 25(1):32. PubMed ID: 38041016
[TBL] [Abstract][Full Text] [Related]
4. Targeting NUFIP1 Suppresses Growth and Induces Senescence of Colorectal Cancer Cells.
Shen A; Wu M; Liu L; Chen Y; Chen X; Zhuang M; Xie Q; Cheng Y; Li J; Shen Z; Wei L; Chu J; Sferra TJ; Zhang X; Xu N; Li L; Peng J; Chen F
Front Oncol; 2021; 11():681425. PubMed ID: 34367967
[TBL] [Abstract][Full Text] [Related]
5. ETV7 promotes colorectal cancer progression through upregulation of IFIT3.
Chai B; Li Y; Guo Y; Zhang Z; Jia K; Chai X; Suo Y
Funct Integr Genomics; 2024 Jan; 24(1):8. PubMed ID: 38200280
[TBL] [Abstract][Full Text] [Related]
6. DR6 Augments Colorectal Cancer Cell Growth, Invasion, and Stemness by Activating AKT/NF-κB Pathway.
Jia J; Huang Y; Chen Q; Hou J; Liu Y; Xie L; Li X; Yang C
Biochem Genet; 2024 Mar; ():. PubMed ID: 38478147
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of NELFCD promotes colorectal cancer cells proliferation, migration, and invasion.
Song S; Li D; Yang C; Yan P; Bai Y; Zhang Y; Hu G; Lin C; Li X
Onco Targets Ther; 2018; 11():8741-8750. PubMed ID: 30584332
[TBL] [Abstract][Full Text] [Related]
8. High Expression Level of TRIP6 is Correlated with Poor Prognosis in Colorectal Cancer and Promotes Tumor Cell Proliferation and Migration.
Ren H; Su Z; Yang J; Cao J; Zhang Y; Sheng K; Guo K; Wang Y
Biochem Genet; 2024 Mar; ():. PubMed ID: 38430448
[TBL] [Abstract][Full Text] [Related]
9.
Jin L; Huang J; Guo L; Zhang B; Li Q; Li H; Yu M; Xie P; Yu Q; Chen Z; Liu S; Xu Y; Xiao Y; Lu M; Ye Q
J Gastrointest Oncol; 2023 Dec; 14(6):2448-2465. PubMed ID: 38196537
[TBL] [Abstract][Full Text] [Related]
10. SERPINH1 promoted the proliferation and metastasis of colorectal cancer by activating PI3K/Akt/mTOR signaling pathway.
Jin XS; Chen LX; Ji TT; Li RZ
World J Gastrointest Oncol; 2024 May; 16(5):1890-1907. PubMed ID: 38764814
[TBL] [Abstract][Full Text] [Related]
11. Leukotriene B4 receptor knockdown affects PI3K/AKT/mTOR signaling and apoptotic responses in colorectal cancer.
Tang C; Wang A; Zhao Y; Mou W; Jiang J; Kuang J; Sun B; Tang E
Biomol Biomed; 2024 Jan; ():. PubMed ID: 38259082
[TBL] [Abstract][Full Text] [Related]
12. WDR12/RAC1 axis promoted proliferation and anti-apoptosis in colorectal cancer cells.
Wen S; Huang X; Xiong L; Zeng H; Wu S; An K; Bai J; Zhou Z; Yin T
Mol Cell Biochem; 2024 Feb; ():. PubMed ID: 38341833
[TBL] [Abstract][Full Text] [Related]
13. CBLC promotes the development of colorectal cancer by promoting ABI1 degradation to activate the ERK signaling pathway.
Li Z; Yan G; Yang M; Liu X; Lian Y; Sun M; Pan W
Transl Oncol; 2024 Jul; 45():101992. PubMed ID: 38743987
[TBL] [Abstract][Full Text] [Related]
14. Dual-Specificity Phosphatase 4 Promotes Malignant Features in Colorectal Cancer Through Cyclic-AMP Response Element Binding Protein/Protein Kinase CAMP-Activated Catalytic Subunit Beta Activation.
Pei W; Yin W; Yu T; Zhang X; Zhang Q; Yang X; Shi C; Shen W; Liu G
Dig Dis Sci; 2024 Jun; ():. PubMed ID: 38824257
[TBL] [Abstract][Full Text] [Related]
15. CCNA2 acts as a novel biomarker in regulating the growth and apoptosis of colorectal cancer.
Gan Y; Li Y; Li T; Shu G; Yin G
Cancer Manag Res; 2018; 10():5113-5124. PubMed ID: 30464611
[TBL] [Abstract][Full Text] [Related]
16. SUMO-Activating Enzyme Subunit 1 Is Associated with Poor Prognosis, Tumor Progression, and Radio-Resistance in Colorectal Cancer.
Wu YJ; Huang ST; Chang YH; Lin SY; Lin WL; Chen YJ; Chien ST
Curr Issues Mol Biol; 2023 Sep; 45(10):8013-8026. PubMed ID: 37886949
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Nrf2 promotes colon cancer progression via ERK and AKT signaling pathways.
Lee YJ; Kim WI; Bae JH; Cho MK; Lee SH; Nam HS; Choi IH; Cho SW
Ann Surg Treat Res; 2020 Apr; 98(4):159-167. PubMed ID: 32274363
[TBL] [Abstract][Full Text] [Related]
18. Abnormal upregulation of NUBP2 contributes to cancer progression in colorectal cancer.
Lan D; Wang J; Sun G; Jiang L; Chen Q; Li S; Qu H; Wang Y; Wu B
Mol Cell Biochem; 2024 Mar; ():. PubMed ID: 38492158
[TBL] [Abstract][Full Text] [Related]
19. GPC2 as a diagnostic and prognostic marker regulated progression of colorectal cancer.
Wang R; Lin X
Arab J Gastroenterol; 2024 Feb; 25(1):51-57. PubMed ID: 38220478
[TBL] [Abstract][Full Text] [Related]
20. Research on the Effect and Mechanism of Selenium on Colorectal Cancer Through TRIM32.
Cai X; Su Y; Ning J; Fan X; Shen M
Biol Trace Elem Res; 2024 May; ():. PubMed ID: 38691306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
